Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
PHGE BiomX Inc
- Stocks
- Healthcare
- NYSEAMERICAN: PHGE
Price (delayed)
$0.4496
Market cap
$11.77M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.53
Enterprise value
-$8,131
BiomX is a clinical-stage biotechnology company developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin, as well as target bacteria
Highlights
BiomX's debt has decreased by 8% YoY and by 3% from the previous quarter
BiomX's net income has shrunk by 141% QoQ but it has increased by 14% YoY
PHGE's EPS has surged by 74% year-on-year but it has dropped by 72% since the previous quarter
Key stats
What are the main financial stats of PHGE
Market
Valuations
Earnings
Shares outstanding
26.18M
Market cap
$11.77M
Enterprise value
-$8,131
Price to earnings (P/E)
N/A
Price to book (P/B)
0.46
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$45.49M
Net income
-$42.71M
EBIT
-$40.16M
EBITDA
-$38.35M
Free cash flow
-$34.23M
Per share
Balance sheet
Liquidity
EPS
-$2.53
EPS diluted
-$7.15
Free cash flow per share
-$1.48
Book value per share
$0.98
Revenue per share
$0
TBVPS
$1.98
Total assets
$45.65M
Total liabilities
$21.16M
Debt
$9.29M
Equity
$24.5M
Working capital
$16.51M
Debt to equity
0.38
Current ratio
3.35
Quick ratio
3
Net debt/EBITDA
0.31
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-78.6%
Return on equity
-149.9%
Return on invested capital
-125.3%
Return on capital employed
-104%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
PHGE stock price
How has the BiomX stock price performed over time
Intraday
2.18%
1 week
-3.35%
1 month
-8.24%
1 year
-86.62%
YTD
-38.42%
QTD
-19.09%
Financial performance
How have BiomX's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$45.49M
Net income
-$42.71M
Gross margin
N/A
Net margin
N/A
BiomX's net income has shrunk by 141% QoQ but it has increased by 14% YoY
PHGE's operating income has shrunk by 75% YoY and by 2.2% QoQ
Price vs fundamentals
How does PHGE's price correlate with its fundamentals
Growth
What is BiomX's growth rate over time
Valuation
What is BiomX stock price valuation
P/E
N/A
P/B
0.46
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
PHGE's EPS has surged by 74% year-on-year but it has dropped by 72% since the previous quarter
The stock's P/B is 70% below its 5-year quarterly average of 1.5 and 25% below its last 4 quarters average of 0.6
Efficiency
How efficient is BiomX business performance
The ROA has plunged by 181% from the previous quarter but it has grown by 29% YoY
PHGE's return on invested capital has dropped by 157% since the previous quarter but it is up by 44% year-on-year
The ROE has soared by 87% year-on-year but it has dropped by 69% since the previous quarter
Dividends
What is PHGE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for PHGE.
Financial health
How did BiomX financials performed over time
The total assets is 116% greater than the total liabilities
BiomX's total liabilities has shrunk by 77% YoY but it has increased by 11% QoQ
The total assets has declined by 44% year-on-year but it rose by 6% since the previous quarter
BiomX's debt is 62% less than its equity
The company's debt to equity has surged by 136% YoY but it fell by 5% QoQ
BiomX's debt has decreased by 8% YoY and by 3% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.